Inhibition Peroxiredoxin‐2 by Capsaicin Ameliorates Rheumatoid Arthritis via ROS‐Mediated Apoptosis in Fibroblast‐Like Synoviocytes

ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing prop...

Full description

Saved in:
Bibliographic Details
Published inMedComm (2020) Vol. 6; no. 6; pp. e70209 - n/a
Main Authors He, Hengkai, Hao, Mingjing, Luo, Piao, Chen, Junhui, An, Yehai, Huang, Jingnan, He, Ruiyi, Du, Qingfeng, Zhang, Qian, Wang, Jigang
Format Journal Article
LanguageEnglish
Published China John Wiley & Sons, Inc 01.06.2025
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2
AbstractList ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L ., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2
ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from ., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.
Author He, Hengkai
Chen, Junhui
Huang, Jingnan
An, Yehai
He, Ruiyi
Zhang, Qian
Hao, Mingjing
Luo, Piao
Du, Qingfeng
Wang, Jigang
AuthorAffiliation 5 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China
4 Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases Guangzhou China
3 Department of Pulmonary and Critical Care Medicine Shenzhen Institute of Respiratory Diseases and Shenzhen Clinical Research Centre for Geriatrics Shenzhen People's Hospital First Affiliated Hospital of Southern University of Science and Technology Second Clinical Medical College of Jinan University Shenzhen Guangdong China
1 Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics School of Traditional Chinese Medicine and School of pharmaceutical Sciences Southern Medical University Guangzhou China
2 State Key Laboratory of Southwestern Chinese Medicine Resource School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu Ch
AuthorAffiliation_xml – name: 5 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China
– name: 3 Department of Pulmonary and Critical Care Medicine Shenzhen Institute of Respiratory Diseases and Shenzhen Clinical Research Centre for Geriatrics Shenzhen People's Hospital First Affiliated Hospital of Southern University of Science and Technology Second Clinical Medical College of Jinan University Shenzhen Guangdong China
– name: 1 Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics School of Traditional Chinese Medicine and School of pharmaceutical Sciences Southern Medical University Guangzhou China
– name: 4 Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases Guangzhou China
– name: 2 State Key Laboratory of Southwestern Chinese Medicine Resource School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu China
Author_xml – sequence: 1
  givenname: Hengkai
  surname: He
  fullname: He, Hengkai
  organization: Chengdu University of Traditional Chinese Medicine
– sequence: 2
  givenname: Mingjing
  surname: Hao
  fullname: Hao, Mingjing
  organization: Second Clinical Medical College of Jinan University
– sequence: 3
  givenname: Piao
  surname: Luo
  fullname: Luo, Piao
  organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases
– sequence: 4
  givenname: Junhui
  surname: Chen
  fullname: Chen, Junhui
  organization: Second Clinical Medical College of Jinan University
– sequence: 5
  givenname: Yehai
  surname: An
  fullname: An, Yehai
  organization: Southern Medical University
– sequence: 6
  givenname: Jingnan
  surname: Huang
  fullname: Huang, Jingnan
  organization: Second Clinical Medical College of Jinan University
– sequence: 7
  givenname: Ruiyi
  surname: He
  fullname: He, Ruiyi
  organization: Southern Medical University
– sequence: 8
  givenname: Qingfeng
  surname: Du
  fullname: Du, Qingfeng
  email: dqf1689@smu.edu.cn
  organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases
– sequence: 9
  givenname: Qian
  surname: Zhang
  fullname: Zhang, Qian
  email: zhangqian408@yeah.net
  organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases
– sequence: 10
  givenname: Jigang
  orcidid: 0000-0002-0575-0105
  surname: Wang
  fullname: Wang, Jigang
  email: jgwang@icmm.ac.cn
  organization: China Academy of Chinese Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40443720$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1uEzEQgFeoiJbSCw-AVuKCkFL8t2vvCUURpZFSBbVwtvwzaRx27WDvBnLjyq3PyJPgJqVqOXCxPZ5vPo3seV4c-OChKF5idIoRIu86E8gpRwQ1T4ojUgsxInVNDx6cD4uTlFYowxXGvEHPikOGGKOcoKPi19QvnXa9C778BDH8cBFsXv3vnzek1NtyotZJOeN8Oe6gdSGqHlJ5uYShU31wthzHfhmzIJUbp8rL-VWuvADrMpeT67DuQ8rJLDhzOgbdqtRnZOa-Qnm19WHjgtlm54vi6UK1CU7u9uPiy9mHz5Pz0Wz-cToZz0aG8boZcW2qRlcMaYWJFZoqrkhlRWOJwAhTyphZQGWsMoTiSrFG1wgLS4lYABhDj4vp3muDWsl1dJ2KWxmUk7uLEK-lir0zLcjKkooTYShtDDM11cAVtxVFOQZWq-x6v3etB92BNeD7qNpH0scZ75byOmwkJpgQLEQ2vLkzxPBtgNTLziUDbas8hCFJSjCjqOYcZfT1P-gqDNHnt8oUEY2g9U746mFL9738_fIMvN0DJoaUIizuEYzk7UjJ25GSu5HKMN7D310L2_-Q8mIyJ_uaPzuV0ZQ
Cites_doi 10.1002/med.21945
10.1038/s41598-022-21788-y
10.1038/s41584-023-00932-6
10.1093/bja/aet308
10.1038/sj.onc.1208530
10.1016/j.canlet.2013.10.002
10.1038/s41467-024-52142-7
10.1136/rmdopen-2019-001084
10.1016/j.addr.2024.115300
10.1016/j.biomaterials.2021.121063
10.1186/s13046-018-0868-2
10.1007/s40265-018-0982-7
10.1038/s41392-023-01331-9
10.2119/molmed.2015.00033
10.1161/HYPERTENSIONAHA.121.18778
10.1016/j.ijbiomac.2024.136620
10.1186/s13075-019-1935-6
10.1126/scitranslmed.abq4419
10.1002/adbi.202300538
10.1136/ard-2022-222708
10.1016/j.ijbiomac.2024.131440
10.1002/jcsm.13120
10.1016/j.biopha.2023.114900
10.7150/ijbs.91751
10.1038/nchembio.2211
10.1002/anie.201907853
10.1111/jgh.13664
10.1053/berh.2001.0195
10.1136/ard-2023-225237
10.1007/s00223-017-0373-1
10.1016/j.redox.2019.101319
10.1002/art.40787
10.1016/j.pharmthera.2022.108177
10.1016/j.cej.2024.155709
10.7150/ijbs.7730
10.1038/nrrheum.2017.49
10.1016/j.bcp.2012.11.016
10.7150/ijbs.69618
10.1186/s13075-017-1308-y
10.1016/j.chembiol.2022.06.011
10.1016/S1875-5364(23)60466-2
10.1038/nprot.2007.173
10.7150/thno.35219
10.1186/s12943-021-01390-y
10.3390/cells8040356
10.1186/s40779-022-00381-4
10.1002/ctm2.1148
10.1016/j.jare.2021.06.023
10.1016/j.cyto.2018.03.005
10.1016/j.biocel.2012.04.016
10.1002/eji.201041316
10.1016/j.clim.2022.108964
10.1161/ATVBAHA.110.210906
10.1016/j.ccr.2010.06.003
10.1038/s41467-021-27948-4
10.1016/j.apsb.2021.12.007
10.1136/ard-2023-224699
ContentType Journal Article
Copyright 2025 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2025 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
– notice: 2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
– notice: 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
K9.
7X8
5PM
DOA
DOI 10.1002/mco2.70209
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
CrossRef
MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2688-2663
EndPage n/a
ExternalDocumentID oai_doaj_org_article_5d25728c339c4c63be7a7d53039ce46a
PMC12122188
40443720
10_1002_mco2_70209
MCO270209
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: National Science and Technology Major Project of China
  funderid: 20242D0523402
– fundername: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China
  funderid: 20241205
– fundername: National Key Research and Development Program of China
  funderid: 2020YFA0908000
– fundername: Science and Technology Project of Guangzhou City
  funderid: 2024A04J4155
– fundername: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China
  grantid: 20241205
– fundername: National Science and Technology Major Project of China
  grantid: 20242D0523402
– fundername: Science and Technology Project of Guangzhou City
  grantid: 2024A04J4155
GroupedDBID 0R~
1OC
24P
53G
7X7
8FI
8FJ
AAHHS
ABUWG
ACCFJ
ACCMX
ADPDF
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
BENPR
CCPQU
EBS
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
INH
ITC
M~E
OK1
OVD
RPM
TEORI
UKHRP
AAMMB
AAYXX
AEFGJ
AGXDD
AIDQK
AIDYY
CITATION
WIN
NPM
K9.
7X8
5PM
ID FETCH-LOGICAL-c4769-7bc59b540ba12d8b3a7a25d89d281013344cfe5cdac2315a49b6018d328feecc3
IEDL.DBID DOA
ISSN 2688-2663
IngestDate Wed Aug 27 01:25:17 EDT 2025
Thu Aug 21 18:36:59 EDT 2025
Fri Jul 11 17:09:55 EDT 2025
Tue Aug 05 09:42:28 EDT 2025
Mon Jun 02 02:24:03 EDT 2025
Wed Aug 06 19:07:10 EDT 2025
Sat Jun 14 09:10:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords activity‐based protein profiling
antioxidant
peroxiredoxin‐2
rheumatoid arthritis
capsaicin
Language English
License Attribution
http://creativecommons.org/licenses/by/4.0
2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4769-7bc59b540ba12d8b3a7a25d89d281013344cfe5cdac2315a49b6018d328feecc3
Notes Funding
Hengkai He, Mingjing Hao, and Piao Luo contributed equally to this work.
This work was supported by the National Science and Technology Major Project of China (2024ZD0523402), National Key Research and Development Program of China (2020YFA0908000), Science and Technology Project of Guangzhou City (2024A04J4155), and Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20241205).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding: This work was supported by the National Science and Technology Major Project of China (2024ZD0523402), National Key Research and Development Program of China (2020YFA0908000), Science and Technology Project of Guangzhou City (2024A04J4155), and Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20241205).
ORCID 0000-0002-0575-0105
OpenAccessLink https://doaj.org/article/5d25728c339c4c63be7a7d53039ce46a
PMID 40443720
PQID 3228983688
PQPubID 5014760
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_5d25728c339c4c63be7a7d53039ce46a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12122188
proquest_miscellaneous_3214306770
proquest_journals_3228983688
pubmed_primary_40443720
crossref_primary_10_1002_mco2_70209
wiley_primary_10_1002_mco2_70209_MCO270209
PublicationCentury 2000
PublicationDate June 2025
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: June 2025
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
– name: Beijing
– name: Hoboken
PublicationTitle MedComm (2020)
PublicationTitleAlternate MedComm (2020)
PublicationYear 2025
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2021; 20
2010; 18
2023; 8
2019; 58
2024; 266
2005; 24
2022; 29
2023; 21
2020; 6
2021; 34
2022; 82
2019; 21
2017; 32
2022; 79
2024; 20
2001; 15
2021; 276
2007; 2
2018; 78
2011; 28
2018; 37
2014; 10
2021; 81
2019; 8
2019; 9
2019; 71
2023; 164
2018; 106
2023; 15
2024; 208
2023; 19
2013; 85
2011; 31
2024; 15
2022; 238
2022; 237
2016; 13
2014; 112
2024; 281
2023; 43
2017; 13
2022; 9
2015; 21
2024; 83
2022; 12
2020; 28
2022; 13
2011; 41
2022; 14
2017; 19
2024; 499
2017; 102
2012; 44
2016; 8
2022; 18
2014; 343
e_1_2_11_32_1
e_1_2_11_55_1
e_1_2_11_30_1
e_1_2_11_57_1
e_1_2_11_36_1
e_1_2_11_13_1
e_1_2_11_34_1
e_1_2_11_53_1
e_1_2_11_11_1
e_1_2_11_29_1
e_1_2_11_6_1
Chen X. (e_1_2_11_60_1) 2021; 81
e_1_2_11_27_1
e_1_2_11_4_1
e_1_2_11_48_1
e_1_2_11_2_1
e_1_2_11_20_1
e_1_2_11_47_1
e_1_2_11_24_1
e_1_2_11_41_1
e_1_2_11_8_1
e_1_2_11_22_1
e_1_2_11_43_1
e_1_2_11_17_1
e_1_2_11_15_1
e_1_2_11_59_1
e_1_2_11_38_1
e_1_2_11_19_1
e_1_2_11_50_1
e_1_2_11_10_1
e_1_2_11_31_1
e_1_2_11_56_1
e_1_2_11_58_1
e_1_2_11_14_1
e_1_2_11_35_1
e_1_2_11_52_1
e_1_2_11_12_1
e_1_2_11_33_1
e_1_2_11_54_1
e_1_2_11_7_1
e_1_2_11_28_1
e_1_2_11_5_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_49_1
Cho J.‐W. (e_1_2_11_45_1) 2011; 28
e_1_2_11_61_1
e_1_2_11_21_1
e_1_2_11_44_1
e_1_2_11_46_1
e_1_2_11_25_1
e_1_2_11_40_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_42_1
e_1_2_11_18_1
e_1_2_11_16_1
e_1_2_11_37_1
e_1_2_11_39_1
Zou L. (e_1_2_11_51_1) 2016; 8
References_xml – volume: 8
  issue: 2
  year: 2023
  article-title: Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1
  publication-title: Advanced Biology
– volume: 15
  start-page: 7791
  issue: 1
  year: 2024
  article-title: Astrocyte‐derived Clusterin Disrupts Glial Physiology to Obstruct Remyelination in Mouse Models of Demyelinating Diseases
  publication-title: Nature Communications
– volume: 85
  start-page: 705
  issue: 6
  year: 2013
  end-page: 717
  article-title: The Nrf2 Cell Defence Pathway: Keap1‐dependent and ‐independent Mechanisms of Regulation
  publication-title: Biochemical Pharmacology
– volume: 102
  start-page: 533
  issue: 5
  year: 2017
  end-page: 546
  article-title: Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications
  publication-title: Calcified Tissue International
– volume: 9
  start-page: 4461
  issue: 15
  year: 2019
  end-page: 4473
  article-title: Vitamin C Kills Thyroid Cancer Cells Through ROS‐dependent Inhibition of MAPK/ERK and PI3K/AKT Pathways via Distinct Mechanisms
  publication-title: Theranostics
– volume: 8
  start-page: 68
  issue: 1
  year: 2023
  article-title: Signaling Pathways in Rheumatoid Arthritis: Implications for Targeted Therapy
  publication-title: Signal Transduction and Targeted Therapy
– volume: 20
  start-page: 4601
  issue: 12
  year: 2024
  end-page: 4617
  article-title: Dissection of Targeting Molecular Mechanisms of Celastrol‐induced Nephrotoxicity viaa Combined Deconvolution Strategy of Chemoproteomics and Metabolomics
  publication-title: International Journal of Biological Sciences
– volume: 106
  start-page: 54
  year: 2018
  end-page: 66
  article-title: Berberine Inhibits IL‐21/IL‐21R Mediated Inflammatory Proliferation of Fibroblast‐Like Synoviocytes Through the Attenuation of PI3K/Akt Signaling Pathway and Ameliorates IL‐21 Mediated Osteoclastogenesis
  publication-title: Cytokine
– volume: 499
  year: 2024
  article-title: Mechanism of Self‐Assembled Celastrol‐Erianin Nanomedicine for Treatment of Breast Cancer
  publication-title: Chemical Engineering Journal
– volume: 2
  start-page: 1269
  issue: 5
  year: 2007
  end-page: 1275
  article-title: Collagen‐induced Arthritis
  publication-title: Nature Protocols
– volume: 34
  start-page: 43
  year: 2021
  end-page: 63
  article-title: Activation of Nrf2/HO‐1 Signaling: An Important Molecular Mechanism of Herbal Medicine in the Treatment of Atherosclerosis via the Protection of Vascular Endothelial Cells From Oxidative Stress
  publication-title: Journal of Advanced Research
– volume: 41
  start-page: 2040
  issue: 7
  year: 2011
  end-page: 2051
  article-title: Nrf2 is Essential for Cholesterol Crystal‐induced Inflammasome Activation and Exacerbation of Atherosclerosis Nrf2 is Essential for Cholesterol Crystal‐induced Inflammasome Activation and Exacerbation of Atherosclerosis
  publication-title: European Journal of Immunology
– volume: 112
  start-page: 337
  issue: 2
  year: 2014
  end-page: 347
  article-title: Capsaicin 8% Patch for Treprostinil Subcutaneous Infusion Site Pain in Pulmonary Hypertension Patients
  publication-title: British Journal of Anaesthesia
– volume: 276
  year: 2021
  article-title: Mutual‐reinforcing Sonodynamic Therapy Against Rheumatoid Arthritis Based on Sparfloxacin Sonosensitizer Doped Concave‐cubic Rhodium Nanozyme
  publication-title: Biomaterials
– volume: 15
  issue: 681
  year: 2023
  article-title: Additive Efficacy of a Bispecific Anti–TNF/IL‐6 Nanobody Compound in Translational Models of Rheumatoid Arthritis
  publication-title: Science Translational Medicine
– volume: 28
  start-page: 785
  issue: 5
  year: 2011
  end-page: 792
  article-title: Proteomic Analysis of Psoriatic Skin Tissue for Identification of Differentially Expressed Proteins: Up‐regulation of GSTP1, SFN and PRDX2 in Psoriatic Skin
  publication-title: International Journal of Molecular Medicine
– volume: 15
  start-page: 805
  issue: 5
  year: 2001
  end-page: 829
  article-title: Metalloproteases and Inhibitors in Arthritic Diseases
  publication-title: Best Practice & Research Clinical Rheumatology
– volume: 343
  start-page: 190
  issue: 2
  year: 2014
  end-page: 199
  article-title: Peroxiredoxin 2 Knockdown by RNA Interference Inhibits the Growth of Colorectal Cancer Cells by Downregulating Wnt/β‐catenin Signaling
  publication-title: Cancer Letters
– volume: 164
  year: 2023
  article-title: Therapeutic Strategies for Rheumatic Diseases and Disorders: Targeting Redox Imbalance and Oxidative Stress
  publication-title: Biomedicine & Pharmacotherapy
– volume: 14
  start-page: 182
  issue: 1
  year: 2022
  end-page: 197
  article-title: Capsaicin Alleviates Cisplatin‐induced Muscle Loss and Atrophy in Vitro and in Vivo
  publication-title: Journal of Cachexia, Sarcopenia and Muscle
– volume: 8
  start-page: 3141
  issue: 7
  year: 2016
  end-page: 3147
  article-title: Relationship Between PI3K Pathway and Angiogenesis in CIA Rat Synovium
  publication-title: American journal of translational research
– volume: 28
  year: 2020
  article-title: PRDX2 protects Against Oxidative Stress Induced by H. pylori and Promotes Resistance to Cisplatin in Gastric Cancer
  publication-title: Redox Biology
– volume: 19
  start-page: 111
  issue: 1
  year: 2017
  article-title: Increased Serum Concentrations of IL‐1 Beta, IL‐21 and Th17 Cells in Overweight Patients With Rheumatoid Arthritis
  publication-title: Arthritis Research & Therapy
– volume: 24
  start-page: 3797
  issue: 23
  year: 2005
  end-page: 3809
  article-title: 2‐Methoxyestradiol‐induced Apoptosis in human Leukemia Cells Proceeds Through a Reactive Oxygen Species and Akt‐dependent Process
  publication-title: Oncogene
– volume: 13
  start-page: 38
  issue: 1
  year: 2016
  end-page: 45
  article-title: Profiling Drugs for Rheumatoid Arthritis That Inhibit Synovial Fibroblast Activation
  publication-title: Nature Chemical Biology
– volume: 6
  issue: 1
  year: 2020
  article-title: Management of Fatigue in Rheumatoid Arthritis
  publication-title: RMD Open
– volume: 19
  start-page: 288
  issue: 5
  year: 2023
  end-page: 306
  article-title: Genetics and Epigenetics of Primary Sjögren Syndrome: Implications for Future Therapies
  publication-title: Nat Rev Rheumatol
– volume: 81
  start-page: 85
  issue: 1
  year: 2021
  end-page: 97
  article-title: METTL3‐mediated M A Modification of ATG7 Regulates Autophagy‐GATA4 Axis to Promote Cellular Senescence and Osteoarthritis Progression
  publication-title: Annals of the Rheumatic Diseases
– volume: 79
  start-page: 906
  issue: 5
  year: 2022
  end-page: 917
  article-title: Capsaicin Attenuates Arterial Calcification through Promoting SIRT6‐Mediated Deacetylation and Degradation of Hif1α (Hypoxic‐Inducible Factor‐1 Alpha)
  publication-title: Hypertension
– volume: 21
  start-page: 730
  issue: 10
  year: 2023
  end-page: 744
  article-title: Tripterygium Hypoglaucum Extract Ameliorates Adjuvant‐induced Arthritis in Mice Through the Gut Microbiota
  publication-title: Chinese Journal of Natural Medicines
– volume: 8
  start-page: 356
  issue: 4
  year: 2019
  article-title: Activation of Nrf2/HO‐1 Pathway and Human Atherosclerotic Plaque Vulnerability:An in Vitro and in Vivo Study
  publication-title: Cells
– volume: 238
  year: 2022
  article-title: Anti‐cancer Activity of Sustained Release Capsaicin Formulations
  publication-title: Pharmacology & Therapeutics
– volume: 13
  start-page: 676
  issue: 1
  year: 2022
  article-title: TNF Antagonist Sensitizes Synovial Fibroblasts to Ferroptotic Cell Death in Collagen‐induced Arthritis Mouse Models
  publication-title: Nature Communications
– volume: 12
  issue: 12
  year: 2022
  article-title: Artemisitene Suppresses Rheumatoid Arthritis Progression via Modulating METTL3‐mediated N6‐methyladenosine Modification of ICAM2 mRNA in Fibroblast‐Like Synoviocytes
  publication-title: Clinical and translational medicine
– volume: 71
  start-page: 703
  issue: 5
  year: 2019
  end-page: 711
  article-title: Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis
  publication-title: Arthritis & Rheumatology
– volume: 10
  start-page: 285
  issue: 3
  year: 2014
  end-page: 295
  article-title: Capsaicin Mediates Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells via Stabilizing and Activating p53
  publication-title: International Journal of Biological Sciences
– volume: 20
  start-page: 101
  issue: 1
  year: 2021
  article-title: CircDIDO1 inhibits Gastric Cancer Progression by Encoding a Novel DIDO1‐529aa Protein and Regulating PRDX2 Protein Stability
  publication-title: Molecular Cancer
– volume: 12
  start-page: 2300
  issue: 5
  year: 2022
  end-page: 2314
  article-title: Celastrol Induces Ferroptosis in Activated HSCs to Ameliorate Hepatic Fibrosis via Targeting Peroxiredoxins and HO‐1
  publication-title: Acta Pharmaceutica Sinica B
– volume: 281
  year: 2024
  article-title: Transcriptome Profiling of Canine Parvovirus 2 Nonstructural Gene 1(CPV2.NS1) Transfected 4T1 Mice Mammary Tumor Cells to Elucidate Its Oncolytic Effects
  publication-title: International Journal of Biological Macromolecules
– volume: 18
  start-page: 88
  issue: 1
  year: 2010
  end-page: 98
  article-title: PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
  publication-title: Cancer Cell
– volume: 32
  start-page: 1212
  issue: 6
  year: 2017
  end-page: 1220
  article-title: Peroxiredoxin‐2 Up‐regulation in Inflammatory Bowel Disease: Friend or Foe?
  publication-title: Journal of Gastroenterology and Hepatology
– volume: 43
  start-page: 1038
  issue: 4
  year: 2023
  end-page: 1067
  article-title: Transient Receptor Potential Vanilloid 1 (TRPV1)‐independent Actions of Capsaicin on Cellular Excitability and Ion Transport
  publication-title: Medicinal Research Reviews
– volume: 44
  start-page: 1223
  issue: 8
  year: 2012
  end-page: 1231
  article-title: Lymphocytes From Rheumatoid Arthritis Patients Have Elevated Levels of Intracellular Peroxiredoxin 2, and a Greater Frequency of Cells With Exofacial Peroxiredoxin 2, Compared With Healthy human Lymphocytes
  publication-title: The International Journal of Biochemistry & Cell Biology
– volume: 83
  start-page: 599
  issue: 5
  year: 2024
  end-page: 607
  article-title: Comparison of the Effect of Treatment With NSAIDs Added to Anti‐TNF Therapy versus Anti‐TNF Therapy Alone on the Progression of Structural Damage in the Spine Over 2 Years in Patients With Radiographic Axial Spondyloarthritis From the Randomised‐controlled CONSUL Trial
  publication-title: Annals of the Rheumatic Diseases
– volume: 13
  start-page: 291
  issue: 5
  year: 2017
  end-page: 301
  article-title: Immunometabolism in Early and Late Stages of Rheumatoid Arthritis
  publication-title: Nature Reviews Rheumatology
– volume: 266
  year: 2024
  article-title: Polysaccharides From Polygonatum Kingianum Collett & Hemsl Ameliorated Fatigue by Regulating NRF2/HO‐1/NQO1 and AMPK/PGC‐1α/TFAM Signaling Pathways, and Gut Microbiota
  publication-title: International Journal of Biological Macromolecules
– volume: 58
  start-page: 14715
  issue: 41
  year: 2019
  end-page: 14723
  article-title: Design, Synthesis, and Phenotypic Profiling of Pyrano‐Furo‐Pyridone Pseudo Natural Products
  publication-title: Angewandte Chemie International Edition
– volume: 208
  year: 2024
  article-title: Therapeutic Delivery Systems for Rheumatoid Arthritis Based on Hydrogel Carriers
  publication-title: Advanced Drug Delivery Reviews
– volume: 82
  start-page: 198
  issue: 2
  year: 2022
  end-page: 211
  article-title: PU.1 Promotes Development of Rheumatoid Arthritis via Repressing FLT3 in Macrophages and Fibroblast‐Like Synoviocytes
  publication-title: Annals of the Rheumatic Diseases
– volume: 9
  start-page: 22
  issue: 1
  year: 2022
  article-title: Celastrol Mitigates Inflammation in Sepsis by Inhibiting the PKM2‐dependent Warburg Effect
  publication-title: Military Medical Research
– volume: 83
  start-page: 550
  issue: 5
  year: 2024
  end-page: 555
  article-title: Shift in Perspective: Autoimmunity Protecting Against Rheumatoid Arthritis
  publication-title: Annals of the Rheumatic Diseases
– volume: 12
  issue: 1
  year: 2022
  article-title: Differential Effects of Periodontal Microbiome on the Rheumatoid Factor Induction During Rheumatoid Arthritis Pathogenesis
  publication-title: Scientific Reports
– volume: 18
  start-page: 2003
  issue: 5
  year: 2022
  end-page: 2017
  article-title: Dissection of Targeting Molecular Mechanisms of Aristolochic Acid‐induced Nephrotoxicity a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics
  publication-title: International Journal of Biological Sciences
– volume: 37
  start-page: 197
  issue: 1
  year: 2018
  article-title: Inhibitory Effects of Low Intensity Pulsed Ultrasound on Osteoclastogenesis Induced in Vitro by Breast Cancer Cells
  publication-title: Journal of Experimental & Clinical Cancer Research
– volume: 237
  year: 2022
  article-title: Peroxiredoxin 4 Regulates Tumor‐cell‐Like Characteristics of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis Through PI3k/Akt Signaling Pathway
  publication-title: Clinical Immunology
– volume: 29
  start-page: 1248
  issue: 8
  year: 2022
  end-page: 1259
  article-title: Capsaicin Ameliorates Inflammation in a TRPV1‐independent Mechanism by Inhibiting PKM2‐LDHA‐mediated Warburg Effect in Sepsis
  publication-title: Cell Chemical Biology
– volume: 21
  start-page: 153
  issue: 1
  year: 2019
  article-title: A Novel Function of artesunate on Inhibiting Migration and Invasion of Fibroblast‐Like Synoviocytes From Rheumatoid Arthritis Patients
  publication-title: Arthritis Research & Therapy
– volume: 21
  start-page: 98
  issue: 1
  year: 2015
  end-page: 108
  article-title: Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release Through a Novel Mechanism of Redox‐Dependent Secretion
  publication-title: Molecular Medicine
– volume: 31
  start-page: 58
  issue: 1
  year: 2011
  end-page: 66
  article-title: NF‐E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
– volume: 78
  start-page: 1489
  issue: 14
  year: 2018
  end-page: 1500
  article-title: Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain
  publication-title: Drugs
– ident: e_1_2_11_13_1
  doi: 10.1002/med.21945
– ident: e_1_2_11_7_1
  doi: 10.1038/s41598-022-21788-y
– ident: e_1_2_11_4_1
  doi: 10.1038/s41584-023-00932-6
– ident: e_1_2_11_39_1
  doi: 10.1093/bja/aet308
– ident: e_1_2_11_17_1
  doi: 10.1038/sj.onc.1208530
– ident: e_1_2_11_44_1
  doi: 10.1016/j.canlet.2013.10.002
– ident: e_1_2_11_50_1
  doi: 10.1038/s41467-024-52142-7
– ident: e_1_2_11_30_1
  doi: 10.1136/rmdopen-2019-001084
– ident: e_1_2_11_35_1
  doi: 10.1016/j.addr.2024.115300
– ident: e_1_2_11_15_1
  doi: 10.1016/j.biomaterials.2021.121063
– ident: e_1_2_11_59_1
  doi: 10.1186/s13046-018-0868-2
– ident: e_1_2_11_38_1
  doi: 10.1007/s40265-018-0982-7
– ident: e_1_2_11_2_1
  doi: 10.1038/s41392-023-01331-9
– ident: e_1_2_11_31_1
  doi: 10.2119/molmed.2015.00033
– ident: e_1_2_11_10_1
  doi: 10.1161/HYPERTENSIONAHA.121.18778
– ident: e_1_2_11_49_1
  doi: 10.1016/j.ijbiomac.2024.136620
– volume: 8
  start-page: 3141
  issue: 7
  year: 2016
  ident: e_1_2_11_51_1
  article-title: Relationship Between PI3K Pathway and Angiogenesis in CIA Rat Synovium
  publication-title: American journal of translational research
– ident: e_1_2_11_33_1
  doi: 10.1186/s13075-019-1935-6
– ident: e_1_2_11_36_1
  doi: 10.1126/scitranslmed.abq4419
– ident: e_1_2_11_23_1
  doi: 10.1002/adbi.202300538
– ident: e_1_2_11_24_1
  doi: 10.1136/ard-2022-222708
– volume: 28
  start-page: 785
  issue: 5
  year: 2011
  ident: e_1_2_11_45_1
  article-title: Proteomic Analysis of Psoriatic Skin Tissue for Identification of Differentially Expressed Proteins: Up‐regulation of GSTP1, SFN and PRDX2 in Psoriatic Skin
  publication-title: International Journal of Molecular Medicine
– ident: e_1_2_11_54_1
  doi: 10.1016/j.ijbiomac.2024.131440
– ident: e_1_2_11_11_1
  doi: 10.1002/jcsm.13120
– ident: e_1_2_11_20_1
  doi: 10.1016/j.biopha.2023.114900
– ident: e_1_2_11_21_1
  doi: 10.7150/ijbs.91751
– ident: e_1_2_11_27_1
  doi: 10.1038/nchembio.2211
– ident: e_1_2_11_9_1
  doi: 10.1002/anie.201907853
– ident: e_1_2_11_46_1
  doi: 10.1111/jgh.13664
– ident: e_1_2_11_29_1
  doi: 10.1053/berh.2001.0195
– ident: e_1_2_11_3_1
  doi: 10.1136/ard-2023-225237
– ident: e_1_2_11_37_1
  doi: 10.1007/s00223-017-0373-1
– ident: e_1_2_11_43_1
  doi: 10.1016/j.redox.2019.101319
– ident: e_1_2_11_28_1
  doi: 10.1002/art.40787
– ident: e_1_2_11_12_1
  doi: 10.1016/j.pharmthera.2022.108177
– ident: e_1_2_11_22_1
  doi: 10.1016/j.cej.2024.155709
– ident: e_1_2_11_40_1
  doi: 10.7150/ijbs.7730
– ident: e_1_2_11_25_1
  doi: 10.1038/nrrheum.2017.49
– ident: e_1_2_11_56_1
  doi: 10.1016/j.bcp.2012.11.016
– ident: e_1_2_11_42_1
  doi: 10.7150/ijbs.69618
– ident: e_1_2_11_47_1
  doi: 10.1186/s13075-017-1308-y
– ident: e_1_2_11_26_1
  doi: 10.1016/j.chembiol.2022.06.011
– ident: e_1_2_11_8_1
  doi: 10.1016/S1875-5364(23)60466-2
– ident: e_1_2_11_32_1
  doi: 10.1038/nprot.2007.173
– ident: e_1_2_11_14_1
  doi: 10.7150/thno.35219
– ident: e_1_2_11_18_1
  doi: 10.1186/s12943-021-01390-y
– ident: e_1_2_11_58_1
  doi: 10.3390/cells8040356
– ident: e_1_2_11_41_1
  doi: 10.1186/s40779-022-00381-4
– ident: e_1_2_11_52_1
  doi: 10.1002/ctm2.1148
– ident: e_1_2_11_53_1
  doi: 10.1016/j.jare.2021.06.023
– ident: e_1_2_11_48_1
  doi: 10.1016/j.cyto.2018.03.005
– ident: e_1_2_11_19_1
  doi: 10.1016/j.biocel.2012.04.016
– ident: e_1_2_11_57_1
  doi: 10.1002/eji.201041316
– ident: e_1_2_11_5_1
  doi: 10.1016/j.clim.2022.108964
– ident: e_1_2_11_55_1
  doi: 10.1161/ATVBAHA.110.210906
– volume: 81
  start-page: 85
  issue: 1
  year: 2021
  ident: e_1_2_11_60_1
  article-title: METTL3‐mediated M 6A Modification of ATG7 Regulates Autophagy‐GATA4 Axis to Promote Cellular Senescence and Osteoarthritis Progression
  publication-title: Annals of the Rheumatic Diseases
– ident: e_1_2_11_16_1
  doi: 10.1016/j.ccr.2010.06.003
– ident: e_1_2_11_6_1
  doi: 10.1038/s41467-021-27948-4
– ident: e_1_2_11_61_1
  doi: 10.1016/j.apsb.2021.12.007
– ident: e_1_2_11_34_1
  doi: 10.1136/ard-2023-224699
SSID ssj0002511790
Score 2.2934387
Snippet ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own...
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues,...
ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e70209
SubjectTerms activity‐based protein profiling
antioxidant
capsaicin
Original
peroxiredoxin‐2
rheumatoid arthritis
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKkRAXxJu0BRnBCSk0sZ3ElriUFauCWFq1VOot8itshBqvNrtV98aVG7-RX8LYyaasQEjcoszEcTwz9pex_Rmhl5VQVa6NjlNtVcxsUsRSMx3z1NpEpTqrTFgg-yk_PGMfzrPzLfRmvRem44cYEm4-MkJ_7QNcqnb_mjT0QjvyugC0I26gm35vrV_QR9jxkGHx4LkISRaSe3eAsXXgJyX7149vjEiBuP9vaPPPRZO_g9kwGo3vojs9jMQHnd3voS3b3Ee3Jv1E-QP0_X0zrVVYjoWP7dxd1Z4Y9Kpufn77QbBa4ZGctdIr44MLaAjvCLbFJ1O7BAjrauOLngbCI3xZS3xydApPTsK5HhaEMzdbuBaEUMAYmtEpQOELUPlYf7X4dNW4y9rpFZT5EJ2N330eHcb9qQuxZkUu4kLpTCgAckqmxHBFZSFJZrgwxJOBUcqYrmymjdSADTPJhIKfOm4o4ZUFh6CP0HbjGvsEYZ5WlFtecAmgpahAKZMioVoKJgmrSIRerFu-nHXkGmVHo0xKb58y2CdCb71RBg1PiB1uuPmXso-vMjPQ9xCuKRXgajlVtpCFyWCAFtqyXEZob23Sso_StoTOjAtOwTsi9HwQQ3z5SRPZWLf0OoAoPc1eEqHHnQcMNWEJ89OeIOEbvrFR1U1JU08Dh3cKkAHQFbz4VXCjf3x_ORkdkXC18z_Ku-g28WcVh4zRHtpezJf2KQCohXoW4uQXXaQbGQ
  priority: 102
  providerName: Wiley-Blackwell
Title Inhibition Peroxiredoxin‐2 by Capsaicin Ameliorates Rheumatoid Arthritis via ROS‐Mediated Apoptosis in Fibroblast‐Like Synoviocytes
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmco2.70209
https://www.ncbi.nlm.nih.gov/pubmed/40443720
https://www.proquest.com/docview/3228983688
https://www.proquest.com/docview/3214306770
https://pubmed.ncbi.nlm.nih.gov/PMC12122188
https://doaj.org/article/5d25728c339c4c63be7a7d53039ce46a
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLZgSIgL4jfZRmUEJ6SwxHZi-7hVqwaiW9UxqbfIdhw1gsXV2k7rjSs3_kb-Ep6drGoFgguXKMp7cRy_Z_tz_PI9hN5WUle5KU2cGqtjZhMeK8NMLFJrE52arCpDgOxpfnLBPk6yyUaqLx8T1tIDtw13kJXgVEQYSiWUkVNtueJlBiOvNJblARrBnLexmPJjsAfOXCZrPlJycGkcec8BHMmtGSgQ9f8JXf4eJLkJXsPsM3iEHnawER-21X2M7tjmCbo_7DbGn6LvH5pprUP4FR7ZK3dTeyLQm7r5-e0HwXqF-2o2V14ZH17ar_6_fMCYeDy1S4Csri590dNAcISva4XHZ-dw5zDk8bAgnLnZws1BCAUMYIXtNKDuBah8qr9YfL5q3HXtzArKfIYuBsef-ydxl2UhNoznMubaZFIDcNMqJaXQVHFFslLIknjyL0oZM5XNTKkMYMFMMalhESdKSkRlwQHoc7TTuMa-RFikFRVWcKEApPAKlDIlE2qUZIqwikTozW3LF7OWTKNoaZNJ4e1TBPtE6MgbZa3hCbDDBXCLonOL4l9uEaH9W5MWXa-cFzB4CSloLkSEXq_F0J_8JolqrFt6HUCQnlYvidCL1gPWNWEJ89ucIBFbvrFV1W1JU08DZ3cKEAHQFDz4XXCjv7x_MeyfkXC2-z9aYg89ID5ncfhytI92FldL-wqA1EL30F3CRnDkE95D946OT0fjXuhHvfDV6xfVhyU6
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSNAL4lkCBYLghBSa2E5sH8uK1RZ226oPqbfIr7BR1Xi1j6p748qN38gvYexNU1YgJG5RZuw4nhn7y9j5jNC7Sqiq0EYnmbYqoTZlidRUJzyzNlWZzisTNsjuF4NT-vksP2v35vh_YVb8EF3CzUdGGK99gPuE9M4Na-iFdvgDA7gjbqM7tMDMH2CA6WGXYvHomYUsCy68P8Dk2hGU4p2b4mtTUmDu_xvc_HPX5O9oNkxH_Qfofosj492V4R-iW7Z5hO6O2pXyx-j7XjOuVdiPFR_aqbuqPTPoVd38_PYDx2oZ9-RkJr1yvHsBPeE9wc7io7FdAIZ1tfFVjwPjUXxZy_jo4BhKjsLBHhaEEzeZuxkIoYI-9KNTAMPnoDKsz218vGzcZe30Eup8gk77n056g6Q9diHRlBUiYUrnQgGSUzLDhisimcS54cJgzwZGCKW6srk2UgM4zCUVCr7quCGYVxY8gjxFG41r7DMU86wi3HLGJaAWVoFSLkVKtBRUYlrhCL297vlysmLXKFc8yrj09imDfSL00Rul0_CM2OGGm34t2wArcwODD-aaEAG-VhBlmWQmhxlaaEsLGaHta5OWbZjOShjNuOAEvCNCbzoxBJhfNZGNdQuvA5DS8-ylEdpaeUDXEppSv-4JEr7mG2tNXZc09TiQeGeAGQBewYPfBzf6x_uXo94BDlfP_0f5Nbo3OBkNy-He_pcXaBP7g4tD-mgbbcynC_sS0NRcvQox8wuVHB6F
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKkSouiHcDBYLghBSa2E5iS1zKwqqFbrtqqdRb5FfYCDWO9lF1b1y58Rv5JYydbMoKhMQtyowdxzNjfxk7nxF6VXJZZkqrKFFGRtTEeSQUVRFLjIllotJS-w2yR9n-Gf14np5voLerf2Fafog-4eYiw4_XLsAbXe5ek4ZeKIvf5IB2-A100632uQ1dmI77DIsDz7lPsuDMuQPMrT0_Kd69Lr42I3ni_r-hzT83Tf4OZv1sNLyDbncwMtxr7X4XbZj6HtoadQvl99H3g3pSSb8dKxybqb2qHDHoVVX__PYDh3IZDkQzE0453LuAjnCOYGbhycQsAMLaSruqJ57wKLysRHhyfAolR_5cDwPCxjZzOwMhVDCEbrQSUPgcVA6rryY8Xdb2srJqCXU-QGfDD58H-1F36kKkaJ7xKJcq5RKAnBQJ1kwSkQucasY1dmRghFCqSpMqLRRgw1RQLuGjjmmCWWnAIchDtFnb2myjkCUlYYblTABoyUtQSgWPiRKcCkxLHKCXq54vmpZco2hplHHh7FN4-wTonTNKr-EIsf0NO_1SdPFVpBrGHswUIRxcLSPS5CLXKUzQXBmaiQDtrExadFE6K2AwY5wR8I4AvejFEF9u0UTUxi6cDiBKR7MXB-hR6wF9S2hM3bInSNiab6w1dV1SVxPP4Z0AZAB0BQ9-7d3oH-9fjAbH2F89_h_l52hr_H5YHB4cfXqCbmF3bLFPHu2gzfl0YZ4ClprLZz5kfgHWJx23
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+Peroxiredoxin-2+by+Capsaicin+Ameliorates+Rheumatoid+Arthritis+via+ROS-Mediated+Apoptosis+in+Fibroblast-Like+Synoviocytes&rft.jtitle=MedComm+%282020%29&rft.au=He%2C+Hengkai&rft.au=Hao%2C+Mingjing&rft.au=Luo%2C+Piao&rft.au=Chen%2C+Junhui&rft.date=2025-06-01&rft.eissn=2688-2663&rft.volume=6&rft.issue=6&rft.spage=e70209&rft_id=info:doi/10.1002%2Fmco2.70209&rft_id=info%3Apmid%2F40443720&rft.externalDocID=40443720
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2688-2663&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2688-2663&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2688-2663&client=summon